These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9022479)
21. Prescribing for thrombophilia--are we going to repeat mistakes of the past? Jivraj S Gynecol Obstet Invest; 2004; 58(4):219; author reply 220. PubMed ID: 15331855 [No Abstract] [Full Text] [Related]
22. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Dendrinos S; Sakkas E; Makrakis E Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178 [TBL] [Abstract][Full Text] [Related]
23. Autoimmunity: effectiveness of treatments for pregnant women with APS. Gelber SE; Salmon JE Nat Rev Rheumatol; 2010 Apr; 6(4):187-9. PubMed ID: 20357787 [No Abstract] [Full Text] [Related]
25. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653 [TBL] [Abstract][Full Text] [Related]
26. Antiphospholipids and pregnancy--a review. Yap C; Yeoh SC; Viegas OA Singapore Med J; 1998 Jul; 39(7):331-4. PubMed ID: 9885698 [TBL] [Abstract][Full Text] [Related]
27. Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss. Wang M; Zhang P; Yu S; Zhou G; Lv J; Nallapothula D; Guo C; Wang Q; Singh RR Clin Immunol; 2019 Nov; 208():108259. PubMed ID: 31513884 [TBL] [Abstract][Full Text] [Related]
28. Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women. Christiansen OB BMJ; 1997 Aug; 315(7104):372; author reply 373. PubMed ID: 9270477 [No Abstract] [Full Text] [Related]
29. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426 [TBL] [Abstract][Full Text] [Related]
30. Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study. Naru T; Khan RS; Ali R East Mediterr Health J; 2010 Mar; 16(3):308-12. PubMed ID: 20795446 [TBL] [Abstract][Full Text] [Related]
31. The obstetric antiphospholipid syndrome. Derksen RH; de Groot PG J Reprod Immunol; 2008 Jan; 77(1):41-50. PubMed ID: 17239960 [TBL] [Abstract][Full Text] [Related]
32. Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up. Naru T; Khurshid M; Nazir Z J Pak Med Assoc; 2006 Feb; 56(2):84-6. PubMed ID: 16555643 [TBL] [Abstract][Full Text] [Related]
34. Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery. Piette JC; Huong DL; Wechsler B BMJ; 1997 Aug; 315(7104):372-3; author reply 373. PubMed ID: 9270479 [No Abstract] [Full Text] [Related]
35. Thrombophilia and pregnancy loss. Regan L; Rai R J Reprod Immunol; 2002; 55(1-2):163-80. PubMed ID: 12062831 [TBL] [Abstract][Full Text] [Related]
36. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Mak A; Cheung MW; Cheak AA; Ho RC Rheumatology (Oxford); 2010 Feb; 49(2):281-8. PubMed ID: 19965971 [TBL] [Abstract][Full Text] [Related]
37. [Recurrent miscarriage and thrombophilia]. Middeldorp S; Goddijn M Ned Tijdschr Geneeskd; 2006 Jan; 150(4):189-93. PubMed ID: 16471233 [TBL] [Abstract][Full Text] [Related]